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Background: Survivin is detected in few adult normal cells and it is highly expressed in cancer. Nuclear survivin facilitates cell cycle
entry, whereas the mitochondrial pool protects cells from apoptosis. Survivin is overexpressed in keratinocyte stem cells (KSCs)
and protects them from apoptosis.
Methods: As KSCs are at the origin of squamous cell carcinoma (SCC), we evaluated survivin expression in normal and cancerous
skin in vivo by immunohistochemistry and western blotting. HaCaT cells overexpressing survivin and wound-healing assay are
used. Analysis of variance and Student’s T-tests are used for statistical analysis.
Results: Survivin is localised in both the cytoplasm and nucleus of normal adult and young keratinocytes. Nuclear survivin is
detected in one every 10 of 11 basal keratinocytes. When present in suprabasal cells, nuclear survivin is coexpressed with K10 but
not with K15 or p75-neurotrophin receptor (p75NTR), a transit amplifying cell marker. Nuclear, but not cytoplasmic, survivin
expression markedly increases in actinic keratosis and in SCC in situ, as compared with normal epidermis, and it is highest
in poorly differentiated SCC. In SCC tumours, nuclear survivin-positive cells are mainly K10/p75NTR-negative and K15-positive.
In poorly differentiated tumours, survivin mostly localises in the deep infiltrating areas. When overexpressed in keratinocytes,
survivin increases cell migration.
Conclusion: High survivin expression and the subcellular localisation of survivin correlate with keratinocyte differentiation and are
associated with undifferentiated and more invasive SCC phenotype.
Cutaneous squamous cell carcinoma (cSCC) is the second most
common non-melanoma skin cancer, with increasing incidence in
the past decades (Martorell-Calatayud et al, 2013). Because the
number of deaths caused by cSCC is now similar to that counted for
melanoma (Martorell-Calatayud et al, 2013), a deepened knowledge
of cSCC biology, including the factors determining cSCC aggressive-
ness, is necessary. According to the new American Joint Committee
on Cancer (AJCC), the degree of cSCC differentiation determines,
along with several other factors, the tumour-specific stage of the
disease (Farasat et al, 2011). In normal skin, epidermal differentiation
is a finely regulated physiologic process, consisting of a progressive
maturation of undifferentiated cells from the basal layers to the skin
surface (Pincelli and Marconi, 2010). Although still under debate
(Boehnke et al, 2012), evidence suggests that cSCC seems to originate
from a mutated keratinocyte stem cell (KSC) located in the basal
layer of interfollicular epidermis (Morris, 2000).
Survivin, an IAP protein with the ability to both block apoptosis
and regulate cell cycle, almost exclusively, marks a population of
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normal human keratinocytes with stem cell characteristics
(Marconi et al, 2007). Interestingly, survivin functions are tightly
associated with its intracellular localisation (Colnaghi et al, 2006).
In particular, the nuclear pool of survivin orchestrates cell division,
whereas mitochondrial survivin protects cells from apoptosis by
preventing caspase activation, when released to the cytoplasm
(Dohi et al, 2004). Finally, survivin can also shift from the nucleus
to the cytoplasm, where its role is not completely defined (reviewed
in Dallaglio et al, 2012), yet being associated with the antiapoptotic
function (Chan et al, 2010), as previously shown for the
mitochondrial pool (Dohi et al, 2004). Survivin is mainly nuclear
in cultured KSC, where it correlates with high proliferative activity,
whereas it is located in the cytoplasm of transit amplifying (TA)
cells (Marconi et al, 2007). In addition, survivin is expressed in the
cytoplasm of basal keratinocytes from normal human skin in vivo
(Marconi et al, 2007). Although survivin is expressed more in
precancerous and cancerous skin than in normal skin (Chiodino
et al, 1999; Lo Muzio et al, 2001; Bowen et al, 2004; Park et al,
2004), a complete understanding of survivin expression in normal,
precancerous and cancerous lesions, with particular regard to the
differentiation stage of the disease, is still lacking. In this work, we
analysed the correlation between survivin intracellular localisation
and the differentiative state of keratinocytes and SCC cells.
We present evidence that survivin is expressed not only in the
cytoplasm but also in the nucleus of basal and suprabasal
keratinocytes. Poorly differentiated cSCC express highest levels of
nuclear survivin (N-surv), whereas its expression decreases in
actinic keratosis (AK) and in more differentiated cSCC. Finally,
N-surv localises mainly in the deepest nests of cSCC, whereas its
overexpression increases keratinocyte migration.
MATERIALS AND METHODS
Clinical samples. Skin samples from normal (adult or young)
individuals, AK, in situ SCC and well-differentiated (WD),
moderately differentiated (MD) or poorly differentiated (PD)
cSCCs were obtained from patients recruited at the Policlinico of
Modena and at the Nuovo Ospedale Civile di Sassuolo (Italy). The
Declaration of Helsinki protocols were followed and patients
signed the informed consent from the Department of Dermatology
and Dermatological Surgery, approved by the Modena Commis-
sion of Ethics (protocol no. 184/10). Inclusion criteria for lesional
skin samples were the presence of the lesion in photo-exposed
areas of the body, patients aged between 50 and 90 years old, no
previous treatment for SCC, lesion sizeX1 cm in diameter. Half of
each sample was fixed for pathological confirmation. Only samples
following the inclusion criteria were analysed. The number of
samples tested are reported in Figure 3A. For normal human skin
analysis, skin biopsies were obtained from sun-exposed areas of the
trunk either from young (0–30 years old) individuals or adult/old
(30–90 years old) individuals.
Western blot analysis. Normal human keratinocytes from both
adult and young individuals, cSCC-derived keratinocytes and
SCC13 cells, were lysed with Chemicon Nucelar Extraction kit
(Chemicon International Inc., Temecula, CA, USA) to perform
subcellular fractionation that separates nuclear and cytosolic
components. Alternatively, HaCaT cells were lysed in RIPA buffer.
Western blotting was performed as described previously (Dallaglio
et al, 2013). Nitrocellulose membranes (Millipore, Billerica, MA,
USA) were incubated with rabbit polyclonal anti-human survivin
antibody (1 : 1000; Abcam, Cambridge, UK), goat polyclonal anti-
enolase antibody (1 : 1000; Santa Cruz Biotechnology, Santa Cruz,
CA, USA) as a cytosolic positive control or with anti-b-actin,
mouse monoclonal antibody (1 : 5000; Sigma, St Louis, MO, USA)
as a loading control. The band intensities were quantitatively
determined using ImageJ software (NIH, Bethesda, MD, USA), and
the intensity of protein levels was normalised to b-actin expression.
Primary cells and cell lines. The spontaneously transformed
keratinocyte line HaCaT was kindly provided by Dr N Fusenig
(DKFZ, Heidelberg, Germany) and cultured in Dulbecco’s
modified Eagle’s medium supplemented with 10% foetal bovine
serum at 37 1C and 5% CO2 as described (Boukamp et al, 1988).
Squamous cell carcinoma 13 cell line (a kind gift from Fiona Watt,
King’s College, London, UK) was cultured in the presence of
mitomycin-C-treated J2-3T3 feeder cells as described previously
(Gandarillas and Watt, 1997). Total keratinocytes were
obtained from normal human epidermis derived from young or
adult individuals as described previously (Marconi et al, 2004).
Briefly, the epidermis was separated from the dermis with forceps,
after overnight incubation with dispase (Roche, Mannheim,
Germany). After treatment of the epidermal sheet with trypsin
0.25%/EDTA 0.02%, total keratinocytes were isolated, then washed
in PBS and finally lysed for western blotting analysis.
Primary cSCC cells were obtained from surgical excision of the
affected areas. Cutaneous squamous cell carcinoma keratinocytes
were obtained by mincing total skin, followed by incubation for 2 h
with dispase (Roche) and Ultrapure Collagenase Type III (Sigma)
at 37 1C. The remaining tissue was incubated at 37 1C for 20min
with trypsin 0.05%/EDTA 0.02%. Once total keratinocytes were
extracted, cells were plated on mitomycin-C treated J2-3T3 feeder
layer at 105 to 3 105 per 100mm dish density, in the keratinocyte
medium (Purdie et al, 2011).
Infection of HaCaT cells. A total of 16 103 per cm2 HaCaT cells
were plated, and 24 h later, infected two times with conditioned
medium containing retrovirus for EGFP (enhanced green fluor-
escent protein) or survivin-EGFP (codified by pcz-CFG5.1-EGFP
or pcz-CFG5.1-survivin-EGFP retroviral vector, a kind gift from
Achim Temme, Technische Universitat, Dresden, Germany) and
polybrene to a final concentration of 0.8 mgml 1. Thereafter, the
culture medium was changed, cells were trypsinised and the
number of EGFP-positive cells was controlled by flow cytometry,
performed as described previously (Temme et al, 2003). Only if the
infection efficiency was at least 80%, HaCaT cells were used for the
experiments.
Scratch wound-healing/migration assay. HaCaT cells were
grown up to 90% confluency in six-well tissue culture plates and
treated with mitomycin C. Scratches were then made on the plates
using a sterile 200 ml plastic tip. The plates were then carefully
washed two times with serum-free medium and fresh culture
medium was gently added onto the plates. The plates were then
monitored over the next 48 h. Photographs were taken on six
different areas to monitor gap closure. The result of each
experiment was expressed as the % of the mean of migrated cells
from six different areas.
Immunohistochemical analysis. Immunohistochemistry for
survivin analysis was performed as follows. Formalin-fixed,
paraffin-embedded tissue was cut into 4-mm sections and mounted
on poly-L-lysine-coated slides. After deparaffinisation and rehy-
dration, the slides were boiled in citrate buffer (pH 6) for 30min.
Then, a primary rabbit polyclonal antibody against N-surv and
cytoplasmic survivin (1 : 300; Abcam) was used in a biotin-free
system where antibody–HRP-labeled antibody complex is visua-
lised using 3,30-diaminobenzidine (ultraView Universal DAB
detection kit; Ventana, Oro Valley, AZ, USA). Negative controls
were run simultaneously by omitting primary antibody while
incubating with buffer. Double staining was continued by
incubating the slides with either 2 mgml 1 mouse anti-p75-
neurotrophin receptor (p75NTR) antibody (Lab Vision Corpora-
tion, Neomarkers, Fremont, CA, USA) or rabbit monoclonal anti-
K10 antibody (1 : 100; Epitomics Inc., Burlingame, CA, USA) or
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rabbit monoclonal anti-K15 (1 : 100; Epitomics Inc.) for 1 h. Slides
were then incubated with secondary antibody anti-mouse (1 : 20;
Dako, Glostrup, Denmark) or anti-rabbit biotinylated antibody
(1 : 300; DakoCytomation, Glostrup, Denmark) for 45min at room
temperature, followed by incubation with anti-mouse alkaline
phosphatase complex for 30min (1 : 20; Dako). After three washes
for 5min in PBS, the slides were stained with Fast blue (Sigma) and
lightly counterstained with Harris haematoxylin (Sigma) for
20min. Staining for N-surv in each nucleus was classified as
positive or negative, based on the evaluations of two independent
observers, in a blinded manner. Four hundred cells were examined
per field at  40 magnification.
To estimate survivin expression, two different evaluation
methods have been used:
i Three to five pictures, representative of the entire lesion,
independently from survivin-positive staining, were taken.
Both positive and negative areas for survivin expression were
included in the calculation.
ii Three to five pictures of areas displaying nuclear staining of
survivin were taken. Only areas with positive staining were
included in the evaluation.
In both cases, the number of stained N-surv-positive cells (both
strongly, moderately and weakly stained) were counted and
normalised to the total number of haematoxylin-positive nuclei.
The mean percentage of positive cells was determined. To evaluate
the frequency of positive nuclei relative to basal cells, 300 basal
cells were examined in at least 4 areas at  40 magnification. The
number of suprabasal and basal-positive nuclei was counted and
expressed as the number of positive nuclei/basal cell. This was
performed on at least three different sections and the results were
reported as a mean. Cytoplasmic survivin and N-surv expression
was scored semiquantitatively as strong (þ þ þ ), moderate
(þ þ ), weak (þ ) or negative ( ). Survivin distribution in
lesional skin has been indicated as localised, when restricted to
precise areas of the lesion, or homogeneous, when equally
distributed.
Statistical analysis. Statistical analysis was performed first by
ANOVA, and, in case of significance (Po0.05), also by post hoc
comparison using Student’s t-test.
RESULTS
N-surv expression in normal human epidermis. Because survivin
is overexpressed in KSC (Marconi et al, 2007; Altieri, 2008),
and stem cell activity is reduced during ageing in several tissues
(Martin et al, 1998; Wagner et al, 2009), we evaluated survivin
expression in the skin from young (0–30 years old) and adult/old
(30–90 years old) individuals. Nuclear and cytoplasmic survivin
was expressed in normal human epidermis from both young
and adult subjects. Although cytoplasmic survivin was present
only in basal cells, N-surv-positive cells were located in the basal
and immediately suprabasal epidermal layers (Figure 1A and
Table 1). In addition, survivin was detected in both nuclear and
cytosolic extracts, although to a greater extent in the latter
fraction in both young and adult epidermis (Figure 1B). The
number of N-surv-positive nuclei was higher in young than in
adult specimens (Table 1). Moreover, N-surv-positive nuclei
were more frequent in basal keratinocytes from young than
from adult epidermis. We then evaluated the differentiation and
stem-associated markers in normal epidermis through a double
staining with survivin (Figure 2). Most N-surv-positive cells
expressed K10, an early differentiation marker in human
epidermis (Fuchs and Green, 1980), in both young and adult
specimens. On the other hand, N-surv-positive cells failed to
express either the putative stem cell marker K15 (Webb et al,
2004) or p75NTR that is mainly localised in TA cells (Truzzi
et al, 2011).
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Figure 1. Expression of nuclear and cytoplasmic survivin in normal epidermis from young and adult individuals. (A) Immunohistochemical analysis
of survivin expression in normal human skin from young and adult individuals. Nuclear survivin is indicated by arrows (bars¼70 mm). (B) Total
keratinocytes from young or adult healthy individuals were isolated, as described in Materials and Methods. Nuclear lysates (NL) and cytosolic
lysates (CL) were made and western blot analysis was performed. Enolase was used as a positive control (CNTRL) for cytosolic extracts; b-actin
was used as a loading control. Band intensity was quantified using Image J software.
Table 1. Semiquantitative expression of nuclear and cytoplasmic survivin
in subjects of different ages
Survivin expression
Positive nuclei
frequency
Case Cytoplasmic
Nuclear
(%)
Nuclear
mean
(%) Age
Pos. nuclei/
basal cells
mean
Young 2 YO þ þ þ þ þ
(7.3)
Young: 5.8 Young 1/6.96
Young 6 YO þ þ þ þ (4.3) Adult 1/11.9
Young 4 YO þ þ þ þ (5.8) Total: 1/
9.43
Adult 35 YO þ þ þ (1.9) Adult: 2.2
Adult 46 YO þ / þ (1.3)
Adult 56 YO þ þ þ (3.5)
Total: 4
Abbreviations: Pos¼positive; YO¼ years old.
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N-surv is overexpressed in AK, in situ SCC and cSCC. To better
clarify the expression pattern of survivin in precancerous and
cancerous skin, AK, in situ SCC and cSCC were included in the
study, and cSCC were divided into three main categories based on
the differentiation grade of the tumour (WD, MD and PD). As
N-surv is expressed more in young epidermis, and cSCC lesions
preferentially occur in adult and old individuals, healthy skin from
adult donors was used as a control. Moreover, being UVB, one of
the most common risk factor associated with cSCC, only skin
biopsies from normal sun-exposed areas were included in the
study. Unlike healthy epidermis, cytoplasmic survivin was absent
in precancerous and cancerous lesions. On the other hand, N-surv-
positive cells were more abundant in AK and in situ SCC than in
normal epidermis. Moreover, in normal epidermis, N-surv-positive
cells were mostly located in basal or in immediately suprabasal
keratinocytes, whereas in precancerous and cancerous lesions, they
were expressed only at the suprabasal level, including the spinous
and the granular layers (Figure 3B and E). In cSCC, N-surv was
expressed more in poorly differentiated tumours than in more
differentiated tumours according to ANOVA and Student’s t-test
(Figure 3C, E and F). To confirm survivin overexpression in the
nucleus of cSCC cells, we obtained nuclear and cytosolic extracts
from SCC13 (Rheinwald and Beckett, 1981) and from cultured
keratinocytes isolated from primary cSCCs (see Materials and
Methods section). Both cSCC cell types expressed more N-surv
than cytoplasmic survivin (Figure 3D).
To compare survivin expression in the different skin lesions, we
calculated the percentage of positive nuclei on the total number of
cells counted in each field. While N-surv was only scattered in
some areas of AK, MD and WD cSCC, it was diffuse and
homogeneously distributed in situ and in PD cSCC (Figure 3C).
To take into account tumour heterogeneity in the evaluation of
survivin distribution in the different lesions, we compared the
results obtained by using two different cell count approaches
(see Materials and Methods). In Figure 3E and Table 2, the
percentage of positive nuclei was calculated by evaluating N-surv
expression in the whole lesion. This was performed by analysing
six distant fields chosen randomly in the lesion area (Method I). By
this method, N-surv was significantly more expressed in AK and
cSCCs than in healthy skin. In addition, N-surv was more
expressed in in situ cSCCs than in WD and MD cSCC, whereas it
was highest in PD tumours. We then analysed N-surv expression
in the same section by using an alternative method based on the
calculation of the percentage of N-surv-positive cells only in areas
in which the positive nuclei were detectable (Method II). In
Figure 3C and Table 3, there is an overall increase in the percentage
of positive cells when compared with that obtained by Method I.
Yet, N-surv-positive cells were still significantly higher in in situ
cSCC and PD tumours than in WD and MD cSCC. On the other
hand, by Method II, no significant difference was observed between
in situ and total cSCC. We can conclude that, depending on the
areas included in the cell count, the percentage of N-surv-positive
cells markedly changes resulting in a significant difference between
in situ and cSCC only when a global evaluation of the lesion is
performed.
N-surv is predominantly expressed in less differentiated cSCC
cells. To better correlate the expression pattern of survivin to the
differentiative state of tumour, we performed a double staining for
survivin and either K10, K15 or p75NTR (Figure 4). In both AK
and in situ SCC, N-surv-positive cells expressed K10, as observed
in the normal epidermis (Figure 2). By contrast, in cSCC lesions,
K10 was irregularly distributed in both basal and suprabasal cells,
and was not expressed in the majority of N-surv-positive cells, this
being more evident in PD cSCC. We detected K15 in all cSCC
lesions, although at different levels. In AK and in in situ SCC, K15
was mainly detected in basal keratinocytes, and it was not
expressed in N-surv-positive cells. On the other hand, in cSCC
lesions, K15 was distributed in all epidermal layers and in most
N-surv-positive cells, with no apparent difference among tumour
categories. Finally, p75NTR, which is irregularly expressed in
normal basal keratinocytes (Figure 2; Truzzi et al, 2011), was
absent in AK and in all cSCC, except for isolated positive cells in a
few cSCC (see arrow) that failed to express N-surv (Figure 4). We
concluded that survivin and p75NTR do not colocalise, as
previously shown in the normal epidermis (Figure 2).
N-surv is expressed in invasive areas of cSCC and sustains cell
migration. Finally, we analysed survivin distribution in different
areas of PD cSCC. Survivin was mainly cytoplasmic and was
located in basal keratinocytes of non-lesional epidermis, far from
the tumour. On the other hand, in areas of apparently healthy skin,
close to the tumour, survivin shifted to the nucleus and it was also
expressed in immediately suprabasal keratinocytes. In the intrae-
pidermal tumour, the number of N-surv-positive cells increased, to
eventually become more numerous in the deepest cell nests of
infiltrating cSCC areas (Figure 5A). Because survivin overexpres-
sion in cancer infiltrates often correlates with tumour metastasis
(Lo Muzio et al, 2001), and some lines of evidence suggests an
involvement of survivin in cell migration (McKenzie et al, 2010),
we wanted to address whether survivin overexpression in deeper
cell nests is associated with the potential of keratinocytes to
migrate. HaCaT cells overexpressing survivin migrated to a
significantly greater extent as compared with mock cells.
(Figure 5B). These data seem to suggest that survivin has an
active role in cSCC cell invasion.
DISCUSSION
Survivin is a key molecule for the maintenance of epidermal
homeostasis (Marconi et al, 2007; Dallaglio et al, 2009). Yet, its
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Figure 2. Survivin and differentiation-related markers in healthy skin.
Double staining of representative young and adult skin for survivin and
either K10, K15 or p75NTR. Fast blue was used as chromogen for K10,
K15 and p75NTR, whereas 3,30-diaminobenzidine was used for survivin.
Representative data of three experiments are shown. Bars¼70mm.
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expression in normal human epidermis of adult individuals has
been controversial. Some reports show that survivin is absent in the
normal epidermis (reviewed in Dallaglio et al, 2012), whereas
others have recently confirmed its presence in basal keratinocytes
(Marconi et al, 2007). Nuclear survivin has been detected in
hyperproliferative skin conditions, such as psoriasis and cancer
(Bowen et al, 2004; Abdou and Hanout, 2008), whereas little is
known on its expression in the normal epidermis. In this study, we
show that the nuclear pool of survivin is expressed in the
normal human epidermis and may identify early-differentiating
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Figure 3. Expression of N-surv in AK, in situ SCC and cSCC. (A) Number of cases of AK, in situ SCC and cSCC analysed for survivin expression by
immunohistochemistry. Cutaneous SCC are divided into WD, MD and PD tumours (see Materials and Methods). (B) Representative
immunohistochemical staining of adult healthy skin, AK and in situ SCC for survivin expression (bars¼70mm). (C) Representative
immunohistochemical staining of WD, MD and PD cSCC for survivin expression (bars¼ 70mm). (D) Squamous cell carcinoma 13 cells and total
keratinocytes from primary cutaneous SCC were isolated as described in Materials and Methods. NL and CL were obtained and western blot
analysis was performed. Enolase was used as a positive control for cytosolic extracts, whereas b-actin was used as a loading control. Band intensity
was quantified using Image J software. (E) Quantification of N-surv-positive cells in lesional and healthy skin by using a ‘whole-lesion evaluation’
approach (Method I, described in Materials and Methods). *Po0.05; **Po0.01. (F) Quantification of N-surv-positive cells in lesional skin by
evaluating areas of the lesions in which survivin staining is positive (Method II, described in Materials and Methods). *Po0.05; **Po0.01.
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keratinocytes in healthy skin. In skin tumours, N-surv correlates
with the differentiation grade of the lesion. The discrepancy with
previous reports is probably due to differences in methodology,
assay sensitivity, specificity of the antibody, variations in assay
conditions or even the age of the donors. To overcome the age bias,
we analysed both young and adult epidermis from healthy
individuals. Higher N-surv positivity and frequency in specimens
from younger individuals suggest ageing as a factor that may
influence survivin expression. As N-surv is involved cell division
(Altieri, 2008), the lower levels in normal skin from older
individuals is in line with the reduced proliferative activity of
aged epidermis (Gilchrest, 1983). On the basis of our previous
results showing survivin overexpression in the nuclei of KSC,
which in turn correlates to their high proliferation index in vitro
(Marconi et al, 2007), we first supposed that in vivo N-surv positive
keratinocytes are proliferating cells. Similarly to the proliferation
marker Ki-67 (Gilhar et al, 2004), N-surv-positive cells are more
numerous in the epidermis from young individuals than from
adult individuals. However, not all N-surv-expressing cells stain for
Ki-67 in human cancerous skin (Bongiovanni et al, 2011). In
addition, in the normal skin, Ki-67-positive cells are usually located
in the basal layer of normal epidermis, whereas N-surv-positive
cells are also detected in suprabasal layers. Therefore, further
studies are needed to elucidate whether all of N-surv-positive cells
are proliferating in healthy skin.
Keratinocyte stem cells are estimated to represent 1 to 10% of
basal keratinocytes (Potten and Hendry, 1973; Li et al, 1998;
reviewed in Cotsarelis et al, 1999). As in the present study
N-surv-positive cells are about 10% of total keratinocytes in the
normal epidermis, one could hypothesise that these cells are
KSC. However, N-surv-positive cells are located in suprabasal
cell layers and express the differentiation marker K10, but not
K15. This suggests that N-surv is not a marker of KCS in vivo but
can identify a population of cells starting the differentiation
process, located at the boundary between the basal and
suprabasal layers. This is consistent with the definition of TA
cells, which are committed to terminal differentiation while
retaining proliferative activity (Marconi et al, 2007). Moreover,
number and functionality of KSC does not change with age
(Stern and Bickenbach, 2007; Giangreco et al, 2008), whereas in
Table 2. Semiquantitative expression of nuclear and cytoplasmic survivin
in precancerous and cancerous lesions
Specimens
Nuclear
survivin
expression
(%) Intensity
Cytoplasmic
surv. exp. Distribution
Healthy
adult skin
2.7±0.01 þ þ /
AK 4.23±0.03 þ þ þ  Localised
In situ SCC 8.41±0.04 þ þ þ  Homogeneous
WD SCC 3.36±0.01 þ þ þ  Localised
MD SCC 4.04±0.03 þ þ þ  Localised
PD SCC 9.01±0.04 þ þ þ  Homogeneous
Total SCC 5.47±0.03 þ þ þ  Localised/
homogeneous
Abbreviations: AK¼ actinic keratosis; cSCC¼ cutaneous squamous cell carcinoma;
MD¼moderately differentiated; PD¼poorly differentiated; WD¼well differentiated.
Table 3. Nuclear survivin expression in precancerous and cancerous
lesions
Lesion type Nuclear survivin expression (%)
AK 11.31±0.06
In situ SCC 20.25±0.1
WD SCC 12.81±0.07
MD SCC 11.93±0.08
PD SCC 24.06±0.04
Total SCC 16.27±0.07
Abbreviations: AK¼ actinic keratosis; cSCC¼ cutaneous squamous cell carcinoma;
MD¼moderately differentiated; PD¼poorly differentiated; WD¼well differentiated.
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Figure 4. Survivin and differentiation-related markers in AK, in situ SCC and cSCC. Fast blue was used as chromogen for K10, K15 and p75NTR,
whereas aminoethyl carbazole (AEC) was used for survivin (bars¼ 70mm). Representative data of four patients per lesion type are shown.
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aged epidermis, TA cells display a reduced efficiency (Charruyer
et al, 2009). P75-neurotrophin receptor is overexpressed by a
subpopulation of TA keratinocytes (Truzzi et al, 2011), and is
involved in early keratinocyte differentiation (unpublished
results). Because N-surv-positive cells do not express p75NTR,
N-surv may identify a subpopulation of TA cells, which is
functionally different from the one expressing p75NTR.
As N-surv-positive cells are also located in suprabasal layers,
they may represent a late TA population.
Survivin overexpression has been reported in different human
cancers, including skin tumours (Altieri, 2001). We have observed
a shift of survivin from the cytoplasm to the nucleus of
keratinocytes in AK, in in situ SCC and in cSCC sections.
Cytoplasmic survivin functions mainly as an inhibitor of apoptosis,
whereas N-surv orchestrates cell division. In skin cancers and
precancerous lesions, both apoptosis and cell cycle are dysregu-
lated. We may speculate that because of the high proliferation rate
observed in these lesions, survivin is preferentially sequestered in
the nucleus to help cancer cells to undergo cell division. Although
the expression of survivin has been previously shown to be
confined to the basal layer in AK, similarly to normal epidermis
(Park et al, 2004), we found N-surv not only in basal cells but also
in suprabasal keratinocytes from AK and cSCC lesions, suggesting
that the appearance of positive nuclei in suprabasal cell layers is a
hallmark of disrupted epidermal homeostasis. The number of
N-surv-positive cells is equal in AK and WD or MD cSCC,
implying that survivin is not a good marker to distinguish
preneoplastic lesions from cSCC, in line with previous reports
(Bongiovanni et al, 2009). Interestingly, the percentage of N-surv-
positive cells was significantly higher in in situ SCC as compared
with WD and MD cSCC. On the other hand, the percentage of
positive cells were comparable between PD cSCC and in situ SCC
and tended to be slightly different only when calculation was
performed in areas of positive survivin staining. This is probably
due to the diffuse distribution of N-surv-positive cells in both
tumour types, whereas the high amount of differentiated cells in
WD and MD tumours, which fail to express survivin, contribute to
the decrease in the percentage of N-surv-positive cells. This also
suggests the existence in cSCC of intratumour heterogeneity, a
phenomenon also occurring in other tumour types, such as breast
cancer (Potts et al, 2012). Survivin expression is significantly
different among cSCCs, depending on the differentiation grade, in
that PD cSCC display higher levels of N-surv than MD and WD
tumours. In addition, when calculation of positive nuclei was
performed taking into account the entire lesion, regardless of the
presence of the staining (Figure 3F), in situ SCC expressed
significantly higher N-surv than total cSCC (Figure 3E), probably
reflecting the lack of large differentiated, survivin-negative, areas in
in situ SCC. In any event, N-surv-positive cells could represent a
reliable indicator to distinguish PD from more differentiated
tumours. In substance, survivin expression correlates with cSCC
aggressiveness, in accordance with previous reports (Lo Muzio
et al, 2001). Consistently, survivin is mainly localised in deeper cell
nests of PD cSCC. The increased ability of survivin-overexpressing
keratinocytes to migrate in wounded areas in vitro further confirms
the relationship between survivin expression and cSCC cell
invasiveness. This is in line with previous reports showing survivin
ability to sustain cell migration in other cutaneous neoplasms such
as melanoma (McKenzie et al, 2010; McKenzie and Grossman,
2012).
Unlike healthy epidermis and precancerous lesions, N-surv-
positive cells become partially negative for K10 and positive for
K15 in cSCC, particularly in PD cSCCs. This may reflect the
extensive dysregulation of differentiation in more aggressive
tumours, which culminates also in the strong K15 expression,
detected in all lesions, at variance with previous results (Abbas and
Bhawan, 2011). Finally, the absence of p75NTR in cancerous
lesions is in line with the proapoptotic effects of this receptor
(Truzzi et al, 2011), which is also reduced in other epithelial
tumours (Yuanlong et al, 2008).
Altogether, these results suggest that N-surv marks cells that
are starting the differentiation process in normal epidermis, and
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Figure 5. Nuclear survivin is overexpressed in invasive SCC and sustains keratinocyte migration. (A) Immunohistochemical analysis of survivin
expression in different areas of a representative PD SCC (bars¼70 mm). (B) Mock or survivin-overexpressing HaCaT cells (confirmed by western
blotting) was scratched for migration assay. Cells were then cultured for 48 h and migrated cells into the scraped area were observed. Six areas
were counted and expressed as the mean of cell migrated per area. Data are expressed as the mean±s.d. of triplicate from three different
experiments. *Po0.05.
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it is associated with a more aggressive phenotype in human
cSCC, possibly contributing to the invasive behaviour of this
tumour.
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